Oric Pharmaceuticals (ORIC) Profit After Tax (2019 - 2026)
Oric Pharmaceuticals (ORIC) posted Profit After Tax of -$35.8 million for Q1 2026, down 18.84% on a QoQ basis from -$30.1 million in Q4 2025, and down 19.14% year-over-year from -$44.2 million in Q1 2025.
Oric Pharmaceuticals (ORIC) Profit After Tax (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals' Profit After Tax history runs 8 years deep, the most recent figure standing at -$35.8 million for Q1 2026.
- Quarterly Profit After Tax fell 19.14% year-over-year to -$35.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$134.8 million (down 1.97% YoY) and the FY2025 annual result came in at -$129.1 million, down 1.05% from the prior year.
- Profit After Tax was -$35.8 million for Q1 2026 at Oric Pharmaceuticals, down from -$30.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$20.3 million in Q2 2022 and bottomed at -$36.6 million in Q4 2024.
- A 5-year average of -$28.3 million and a median of -$26.8 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax tumbled 44.94% — and 2025, when it gained 17.88%.
- Oric Pharmaceuticals' Profit After Tax stood at -$20.4 million in 2022, then tumbled by 31.34% to -$26.8 million in 2023, then plunged by 36.85% to -$36.6 million in 2024, then grew by 17.88% to -$30.1 million in 2025, then fell by 18.84% to -$35.8 million in 2026.
- Business Quant data shows ORIC's Profit After Tax at -$35.8 million in Q1 2026, -$30.1 million in Q4 2025, and -$32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Oric Pharmaceuticals | 1.15 Bn | 866.67 Mn | - | -35.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.77 Mn |
| Dec 31, 2025 | -30.10 Mn |
| Sep 30, 2025 | -32.59 Mn |
| Jun 30, 2025 | -36.38 Mn |
| Mar 31, 2025 | -30.02 Mn |
| Dec 31, 2024 | -36.65 Mn |
| Sep 30, 2024 | -33.59 Mn |
| Jun 30, 2024 | -31.96 Mn |
| Mar 31, 2024 | -25.01 Mn |
| Dec 31, 2023 | -26.78 Mn |
| Sep 30, 2023 | -25.48 Mn |
| Jun 30, 2023 | -22.94 Mn |
| Mar 31, 2023 | -23.95 Mn |
| Dec 31, 2022 | -20.39 Mn |
| Sep 30, 2022 | -25.35 Mn |
| Jun 30, 2022 | -20.29 Mn |
| Mar 31, 2022 | -23.86 Mn |
| Dec 31, 2021 | -22.80 Mn |
| Sep 30, 2021 | -18.43 Mn |
| Jun 30, 2021 | -21.01 Mn |